series-a
Stage
1
Investors
About
Invictus Oncology is a biopharmaceutical company focused on developing novel cancer therapeutics using its proprietary platform technology to design drugs that selectively attack cancer cells.
Explore Invictus Oncology's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.